Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1)

Vaccine

Volumn 24, Issue 37-39, 2006, Pages 6256-6263

  Dory, Daniel ^a   Fischer, Timo ^b   Béven, Véronique ^a   Cariolet, Roland ^a   Rziha, Hanns Joachim ^b   Jestin, André ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Aujeszky's disease; DNA prime; Pseudorabies virus; Recombinant Orf virus boost; Sindbis virus derived plasmid; Swine

Indexed keywords

DNA VACCINE; PLASMID VECTOR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS GLYCOPROTEIN GC; VIRUS GLYCOPROTEIN GD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; INFECTION RISK; NONHUMAN; PLASMID; POXVIRUS; PRIORITY JOURNAL; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; SINDBIS VIRUS; SURVIVAL; SWINE; SYMPTOM; VACCINATION; VIRUS RECOMBINANT; VIRUS SHEDDING; WEIGHT REDUCTION;

ANIMALS; HERPESVIRUS 1, SUID; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; INTERLEUKIN-4; ORF VIRUS; PSEUDORABIES; RNA, MESSENGER; SINDBIS VIRUS; SWINE; SWINE DISEASES; TH1 CELLS; TH2 CELLS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 33747341093     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.078     Document Type: Article

References (37)

1. McShane H., Brookes R., Gilbert S.C., and Hill A.V. Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun 69 2 (2001) 681-686
2. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292 5514 (2001) 69-74
3. McConkey S.J., Reece W.H., Moorthy V.S., Webster D., Dunachie S., Butcher G., et al. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med 9 6 (2003) 729-735
4. Moorthy V.S., Imoukhuede E.B., Milligan P., Bojang K., Keating S., Kaye P., et al. A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. Plos Med 1 2 (2004) e33
5. McShane H., and Hill A. Prime-boost immunisation strategies for tuberculosis. Microbes Infect 7 5-6 (2005) 962-967
6. Gerdts V., Jöns A., Makoschey B., Visser N., and Mettenleiter C. Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol 78 (1997) 2139-2146
7. van Rooij E.M.A., Haagmans B.L., de Visser Y.E., de Bruin M.G.M., Boersma W., and Bianchi A.T.J. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet Immunol Immunopathol 66 2 (1998) 113-126
8. Dufour V., Chevallier S., Cariolet R., Somasundaram S., Lefèvre F., Jestin A., et al. Induction of porcine cytokine mRNA expression after DNA immunization and pseudorabies virus infection. J Interferon Cytokine Res 20 10 (2000) 885-890
9. Laval F., Paillot R., Bollard S., Fischer L., Audonnet J.C., Andreoni C., et al. Quantitative analysis of the antigen-specific IFNgamma+T cell-mediated immune response in conventional outbred pigs: kinetics and duration of the DNA-induced IFNgamma+CD8+T cell response. Vet Immunol Immunopathol 90 3-4 (2002) 191-201
10. Hong W., Xiao S., Zhou R., Fang L., He Q., Wu B., et al. Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets. Vaccine 20 7-8 (2002) 1205-1214
11. Dufour V., and De Boisseson C. Use of a Sindbis virus DNA-based expression vector for induction of protective immunity against pseudorabies virus in pigs. Vet Immunol Immunopathol 93 3-4 (2003) 125-134
12. Fischer L., Barzu S., Andreoni C., Buisson N., Brun A., and Audonnet J.C. DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseudorabies virus challenge. Vaccine 21 15 (2003) 1732-1741
13. Dory D., Torché A.M., Béven V., Blanchard P., Loizel C., Cariolet R., et al. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins. Vaccine 23 26 (2005) 3483-3491
14. Dory D., Béven V., Torché A.M., Bougeard S., Cariolet R., and Jestin A. CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs. Vaccine 23 36 (2005) 4532-4540
15. van Rooij E.M., Glansbeek H.L., Hilgers L.A., te Lintelo E.G., de Visser Y.E., Boersma W.J., et al. Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant. J Virol 76 20 (2002) 10540-10545
16. Xiao S., Chen H., Fang L., Liu C., Zhang H., Jiang Y., et al. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22 3-4 (2004) 345-351
17. Dubensky Jr. T.W., Driver D.A., Polo J.M., Belli B.A., Latham E.M., Ibanez C.E., et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol 70 1 (1996) 508-519
18. Hariharan M.J., Driver D.A., Townsend K., Brumm D., Polo J.M., Belli B.A., et al. DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol 72 2 (1998) 950-958
19. Leitner W.W., Ying H., Driver D.A., Dubensky T.W., and Restifo N.P. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res 60 1 (2000) 51-55
20. Kirman J.R., Turon T., Su H., Li A., Kraus C., Polo J.M., et al. Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect Immun 71 1 (2003) 575-579
21. Fischer T., Planz O., Stitz L., and Rziha H.J. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J Virol 77 17 (2003) 9312-9323
22. Henkel M., Planz O., Fischer T., Stitz L., and Rziha H.J. Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J Virol 79 1 (2005) 314-325
23. Buttner M., and Rziha H.J. Parapoxviruses: from the lesion to the viral genome. J Vet Med B Infect Dis Vet Public Health 49 1 (2002) 7-16
24. Stellmann C., Vannier P., Chappuis G., Brun A., Dauvergne M., Frageaud D., et al. The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. J Biol Stand 17 1 (1989) 17-27
25. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedebergs. Arch. Exper. Path. Pharmakol. 162 4 (1931) 480-483
26. Vannier P., Hutet E., Bourgueil E., and Cariolet R. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines. Vet Microbiol 29 3-4 (1991) 213-223
27. Mann H.B., and Withney D.R. On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 18 (1947) 50-60
28. Vannier P. Technical requirements for the licensing of pseudorabies (Aujeszky's disease) vaccines in the European Union. Adv Vet Med 41 (1999) 615-626
29. Vannier P., Hutet E., and Cariolet R. Influence of passive immunity on pig immunization with deleted Aujeszky's disease vaccines measured by the amount of wild virus excretion after challenge. Vet Microbiol 43 1 (1995) 53-63
30. Nauwynck H.J., Zonnekeyn V., and Pensaert M.B. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines. Zentralbl Veterinarmed [B] 44 10 (1997) 609-615
31. Visser N. Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus. Vet Microbiol 55 1-4 (1997) 61-74
32. Gerdts V., Jons A., and Mettenleiter T.C. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs. Vet Microbiol 66 1 (1999) 1-13
33. Wittmann G. Spread and control of Aujeszky's disease (AD). Comp Immunol Microbiol Infect Dis 14 2 (1991) 165-173
34. Haagmans B.L., van Rooij E.M.A., Dubelaar M., Kimman T.G., Horzinek M.C., Schijns V.E.C.J., et al. Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D. Vaccine 17 9-10 (1999) 1264-1271
35. Zuckermann F.A. Aujeszky's disease virus: opportunities and challenge. Vet Res 31 (2000) 121-131
36. van Rooij E.M., de Bruin M.G., de Visser Y.E., Middel W.G., Boersma W.J., and Bianchi A.T. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. Vet Immunol Immunopathol 99 1-2 (2004) 113-125
37. van Rooij E.M., Moonen-Leusen H.W., de Visser Y.E., Middel W.G., Boersma W.J., and Bianchi A.T. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines. Vaccine 24 9 (2006) 1264-1273